C. Sekaggya

Title: Cytokeratin-18 has potential as a biomarker of drug-induced liver injury in European and African patients on treatment for tuberculosis Running Title: K18 in tuberculosis treatment Keywords: cytokeratin-18, K18, drug-induced liver injury, tuberculosis

J. Dear, K. Dhaliwal, A. Hill, 2020 .

High Mycobacterium tuberculosis Bacillary Loads Detected by Tuberculosis Molecular Bacterial Load Assay in Patient Stool: a Potential Alternative for Nonsputum Diagnosis and Treatment Response Monitoring of Tuberculosis

S. Gillespie, M. Joloba, W. Worodria, 2022, Microbiology spectrum.

Nutritional status and its associated factors among HIV adolescents on second line regimen at Pediatric Infectious Diseases Clinic in Uganda

J. Ssenkusu, M. Nicol, S. Kitaka, 2022, Journal of HIV/AIDS & Social Services.

Nutritional status and its associated factors among HIV positive adolescents on Atazanavir-based regimen attending an urban clinic in Uganda

M. Nicol, J. Ssenkusu, S. Kitaka, 2020, medRxiv.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Genetic factors associated with tuberculosis-related clinical outcomes in HIV-infected Black-African patients: a systematic review and meta-analysis.

S. Walimbwa, Innocent Gerald Asiimwe, C. Sekaggya, 2021, Pharmacogenomics.